Safeway (NYSE: SWY ) is leaving the Canadian market.
On Wednesday, the American supermarket chain announced that it has signed a definitive agreement to sell its Canadian operations to�wholly owned Empire Company Limited subsidiary Sobeys, a Canadian food retailer, for $5.7 billion. Sobeys will also take on "certain liabilities" as part of its purchase.
Safeway CEO Robert Edwards characterized the sale as motivated by a desire to take advantage of "the higher multiples attributed to Canadian supermarket companies" as compared with U.S. supermarket chains. Edwards noted that the net proceeds from this sale after taxes and expenses -- just under $4 billion -- will be used to pay down some of Safeway's debt and to buy back stock.
Safeway currently has about $6.2 billion in debt on its books (against $357 million in cash). It has more than 237 million shares outstanding, which, at $23.11 apiece, adds up to a market cap of $5.5 billion -- a market cap, though, that is rapidly climbing in the wake of positive investor reaction to news of the sale.
Best Stocks To Watch Right Now: Buckeye Partners L.P. (BPL)
Buckeye Partners, L.P. owns and operates refined petroleum products pipeline systems in the United States. Its Pipelines & Terminals segment transports refined petroleum products; and provides bulk storage and terminal throughput services in the continental United States. This segment owns and operates approximately 6,000 miles of pipeline serving approximately 110 delivery locations; and has 100 active products terminals with aggregate storage capacity of approximately 40 million barrels. The company’s International Operations segment provides marine terminal throughput, marine bulk storage, and other related services. This segment operates through two petroleum product terminals located on Grand Bahama Island, in The Bahamas and in Puerto Rico with an aggregate storage capacity of approximately 30 million barrels. Its Natural Gas Storage segment provides natural gas storage services through a facility with approximately 30 billion cubic feet of working natural gas storage capacity located in Northern California. The company’s Energy Services segment engages in the wholesale distribution of refined petroleum products, including gasoline; propane; ethanol; biodiesel; and petroleum distillates, such as heating oil, diesel fuel, and kerosene to wholesalers and commercial users. Its Development and Logistics segment provides contract operations, construction management, and asset development services to third-party pipeline and energy assets, and energy companies in the United States. This segment owns and operates 2 underground propane storage caverns with approximately 800,000 barrels of throughput and storage capability in Indiana and Illinois; and a 30-mile ammonia pipeline and 25 miles of pipeline in Texas. Buckeye GP LLC serves as the general partner of the company. Buckeye Partners, L.P. was founded in 1886 and is headquartered in Houston, Texas.Advisors' Opinion:
- [By David Dittman]
Question: If I’m relying on dividends for income, does it make sense to sell some or all shares because the price went up 50 percent, Buckeye Partners LP (NYSE: BPL) for example?
Top 5 Supermarket Companies To Watch In Right Now: Aeon Metals Ltd (AQR)Aeon Metals Limited is an Australia-based company. Its principal activity is exploration of the Rawbelle tenement for porphyry copper/molybdenum mineralization near Monto, Queensland. The principal project is the Greater Whitewash Polymetallic Project, which consists of four deposits over a strike length of five kilometers and width of one kilometer. Its other projects include Kiwi Carpet, Kildare Project, Juicy Fruit, and Anomaly 7B. As of June 30, 2012, it controlled seven contiguous exploration permits for minerals (EPMs): 14628, 15920, 15921, 15922, 17001, 17702, 17060, which are 100% held by the Company and three contiguous EPMs at Kidare: 14627, 15919, and 18202. During the fiscal year ended June 30, 2012 (fiscal 2012), it drilled 37 holes for 9,112 meters, being7, 440 meters reverse circulation (RC) and 1672 meters of diamond drilling (DD) on Rawbelle tenement. As of June 30, 2012, Kiwi Carpet porphyry copper area has had 20 drill holes which returned grades of copper. Advisors' Opinion:
- [By Marc Chandler]
3. The flash euro area PMIs, due Thursday, stand out as the most market sensitive economic data from the euro area. Although the sentiment has been running ahead of real sector data, slight positive growth has replaced the recent contraction. Next Wednesday, the ECB is expected to unveil the broad details of the Asset Quality Review (AQR). This is not a stress test. It is a preliminary review of the books of the banks for which it will soon have supervisory responsibilities. Definitions of risk-weighted assets various in the euro area and some uniformity is a necessary condition of a banking union. New stress tests will be conducted next year.
Top 5 Supermarket Companies To Watch In Right Now: Pernix Therapeutics Holdings Inc (PTX)
Pernix Therapeutics Holdings, Inc. (Pernix), incorporated in November 8, 1996, is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products for pediatric and adult indications in a range of therapeutic areas. It manages a portfolio of branded and generic products and theobromine, a non-codeine, cough suppressant product candidate in development. The Company�� branded products for the pediatrics market include CEDAX, an antibiotic for middle ear infections, NATROBA, a topical treatment for head lice marketed under an exclusive co-promotion agreement with ParaPRO, LLC and a family of prescription treatments for cough and cold (BROVEX, ALDEX and PEDIATEX). It also markets REZYST IM, which is a probiotic blend to promote dietary management. Pernix markets generic products through its wholly owned subsidiary, Macoven Pharmaceuticals, LLC. In January 2013, the Company acquired Cypress Pharmaceuticals, Inc. and Hawthorn Pharmaceuticals, Inc. In March 2013, the Company acquired Somaxon Pharmaceuticals Inc. In September 2013, Pernix Therapeutics Holdings, Inc. completed the sale of certain non-core assets to Breckenridge Pharmaceutical, Inc.
The Company�� customers consist of drug wholesalers, retail drug stores, mass merchandisers and grocery store pharmacies in the United States. It primarily sells products directly to drug wholesalers, which in turn distribute the products to retail drug stores, mass merchandisers and grocery store pharmacies.
ALDEX is a line of antihistamines, decongestants and cough suppressants that are indicated for the temporary relief of respiratory allergies, allergic rhinitis and symptoms of the common cold. The Company�� ALDEX product line is marketed in a range of formulations and combinations using different drug-delivery methodologies to target specific segments of the antihistamine, decongestant and cough suppressant markets. Two used decongestants ar! e phenylephrine and pseudoephedrine.
The BROVEX line is a line of antihistamine combinations with the active pharmaceutical ingredient (API) brompheniramine maleate, part of the first generation class of antihistamines called alkylamines that are indicated for the temporary relief of sneezing, itchy, watery eyes, itchy nose or throat, and runny nose due to hay fever or other respiratory allergies. Its BROVEX product line is marketed in a range of formulations and combinations to target specific segments of the antihistamine market. The Company completed the conversion of the BROVEX product family to over-the-counter (OTC) monograph from DESI drugs, in April 2011.
CEDAX is a third generation oral cephalosporin indicated for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza or streptococcus pyogenes. The Company sells a range of dosages utilizing both capsule and oral suspension drug delivery methodologies. It also owns a trademark on the name CEDAX in the United States.
NATROBA Topical Suspension is a prescription medicine used to treat head lice (pediculosis capitis) in adults and children four years of age and older. NATROBA contains the active ingredient spinosad, which is derived from a naturally occurring soil bacterium.
As of December 31, 2011, the only product that the Company marketed and sold in its PEDIATEX line is PEDIATEX TD. PEDIATEX TD is an antihistamine/nasal decongestant combination liquid for oral administration. Each 1 milliliter dose contains the API Tripolidine HC1 and Pseudoephedrine HC1. Tripolidine HC1 is a first generation antihistamine in the alkylamine class. Pseudoephedrine, a decongestant, is a sympathomimetic, which acts on alpha-adrenergic receptors in the mucosa of the respiratory tract, producing vasoconstriction and having minimal eff! ect on be! ta-receptors. It therefore functions as an oral nasal decongestant with minimal central nervous system stimulation.
REZYST IM is a probiotic blend that promotes the dietary management of patients with the distinctive nutritional requirements associated with the gastro-intestinal flora. It is formulated to improve the digestive health of patients by replacing the active cultures altered by diet, stress, and antibiotics.
Product Candidates in Development
Product candidates in development include Theobromine. Theobromine is an alkaloid naturally present in dark chocolate which is an existing human metabolite of caffeine. The Company is working on several other product candidates, which includes a prescription product for the pediatrics market. In March 2012, the Company entered into a product development agreement with a private company for this product.Advisors' Opinion:
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Wednesday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Horizon Pharma (NASDAQ: HZNP) and Pernix Therapeutics Holdings (NASDAQ: PTX). In trading on Wednesday, telecommunications services shares were relative laggards, down on the day by about 0.39 percent. Top decliners in the sector included Shenandoah Telecommunications Co (NASDAQ: SHEN), off 3.3 percent, and CalAmp (NASDAQ: CAMP), down around 2.4 percent.
- [By John Udovich]
Since the start of 2014, small cap pharmaceutical stocks�Achillion Pharmaceuticals, Inc (NASDAQ: ACHN), Pernix Therapeutics Holdings Inc (NASDAQ: PTX) and Amicus Therapeutics, Inc (NASDAQ: FOLD)�are up 286.3%, 262.3% and 248.1%, respectively, making them some of the best performing pharmaceutical stocks for the year. However, a one year share performance, especially for anything in the volatile biotech or pharmaceutical sector, could be just a one time fluke. With that in mind, here is what you need to know or be warned about all three small cap pharmaceutical stocks:
- [By Michael Douglass and David Williamson]
Shares of�Pernix Therapeutics� (NASDAQ: PTX ) soared 31% yesterday after the company revealed that it had bought the U.S. rights to�GlaxoSmithKline's (NYSE: GSK ) Treximet (which helps treat migraines in adults) for $250 million upfront (and some potential additional payments later). The importance of this purchase cannot easily be overstate for Pernix -- the company had $85 million in revenue last year, while Treximet on its own brought in $79 million -- and Pernix clearly sees some additional upside potential for the drug, whether it's through a potential indication expansion (to pediatric patients) or through synergies with Pernix's current salesforce.
Top 5 Supermarket Companies To Watch In Right Now: PowerShares Dynamic Large Cap Growth Portfolio (PWB)
PowerShares Dynamic Large Cap Growth Portfolio (the Fund) seeks investment results that correspond generally to the price and yield of an equity index called the Dynamic Large Cap Growth Intellidex Index (the Intellidex). The Fund will normally invest at least 80% of its assets in common stocks of large-cap companies. A company is considered to be a large-cap company if it falls within the Intellidex model. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Intellidex. The Intellidex consists of 50 United States large-cap growth stocks selected principally on the basis of their capital appreciation potential as identified by the AMEX (the Intellidex Provider) pursuant to its Intellidex methodology.
The Fund, using an indexing investment approach, attempts to replicate the performance of the Intellidex. The Fund generally will invest in all of the stocks comprising the Intellidex in proportion to their weightings in the Intellidex. The Fund�� investment advisor is PowerShares Capital Management LLC.Advisors' Opinion:
- [By Paul Ausick]
Two ETFs to watch are Guggenheim Solar (NYSEMKT: TAN), which is up more than 80% so far this year, and PowerShares WilderHill Clean Energy (NYSEMKT: PWB), up more than 40%. Both are less liquid than the company shares and their gains have been smaller, but both should do well if the solar stocks keep running up.